Schroder Investment Management Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.84M | Sell |
56,989
-47,928
| -46% | -$8.27M | 0.01% | 641 |
|
|
2025
Q1 | $16.2M | Buy |
104,917
+12,189
| +13% | +$1.89M | 0.02% | 555 |
|
|
2024
Q4 | $12.7M | Buy |
92,728
+11,739
| +14% | +$1.6M | 0.01% | 603 |
|
|
2024
Q3 | $11.7M | Buy |
80,989
+36,071
| +80% | +$5.22M | 0.01% | 633 |
|
|
2024
Q2 | $6.13M | Buy |
+44,918
| New | +$6.13M | 0.01% | 736 |
|
|
2023
Q2 | – | Sell |
-60,221
| Closed | -$6.46M | – | 1229 |
|
|
2023
Q1 | $6.46M | Hold |
60,221
| – | – | 0.01% | 732 |
|
|
2022
Q4 | $7.35M | Buy |
60,221
+2,094
| +4% | +$256K | 0.01% | 700 |
|
|
2022
Q3 | $6M | Buy |
58,127
+6,953
| +14% | +$718K | 0.01% | 732 |
|
|
2022
Q2 | $4.76M | Buy |
51,174
+869
| +2% | +$80.8K | 0.01% | 798 |
|
|
2022
Q1 | $5.84M | Buy |
50,305
+13,362
| +36% | +$1.55M | 0.01% | 802 |
|
|
2021
Q4 | $4.97M | Buy |
36,943
+1,695
| +5% | +$228K | 0.01% | 760 |
|
|
2021
Q3 | $5.62M | Buy |
35,248
+12,468
| +55% | +$1.99M | 0.01% | 763 |
|
|
2021
Q2 | $3M | Buy |
22,780
+1,723
| +8% | +$227K | ﹤0.01% | 938 |
|
|
2021
Q1 | $2.71M | Buy |
21,057
+2,110
| +11% | +$272K | ﹤0.01% | 954 |
|
|
2020
Q4 | $3.16M | Sell |
18,947
-441
| -2% | -$73.6K | ﹤0.01% | 909 |
|
|
2020
Q3 | $3.08M | Buy |
19,388
+1,659
| +9% | +$263K | ﹤0.01% | 820 |
|
|
2020
Q2 | $2.62M | Buy |
17,729
+3,191
| +22% | +$472K | ﹤0.01% | 781 |
|
|
2020
Q1 | $1.72M | Buy |
14,538
+46
| +0.3% | +$5.44K | ﹤0.01% | 820 |
|
|
2019
Q4 | $2.02M | Hold |
14,492
| – | – | ﹤0.01% | 877 |
|
|
2019
Q3 | $1.39M | Buy |
+14,492
| New | +$1.39M | ﹤0.01% | 939 |
|